Plug in the defaults to see what each dose delivers: Skincare (2.5 mL water with GHK-Cu anchor) Payload: GHK-Cu 2 mg BPC-157 0.4 mg TB-4 0.4 mg
Cost, convenience, and medical need all play a role in determining the best option for each individual
PL BioScience has advanced an oral BPC-157 formulation (designated PL-10) to Phase II clinical trials for inflammatory bowel disease representing the most clinically advanced human development of oral BPC-157 to date.3 Human peer-reviewed results from these trials are pending, but the preclinical rationale is strong
Genetic predisposition, loss of immunological tolerance, and various environmental factors contribute to its development
This peptide may help alleviate insomnia and irregular sleep patterns for enhanced well-being
Non-Covered Uses of B12 Injections Medicare does not cover B12 injections intended for non-medically necessary uses, such as strengthening tendons or ligaments